Improvement in clinical outcomes and replacement factor VIII use in patients with haemophilia A after factor VIII pharmacokinetic-guided prophylaxis based on Bayesian models with myPKFiT®-Reference-Cited by-同舟云学术

Improvement in clinical outcomes and replacement factor VIII use in patients with haemophilia A after factor VIII pharmacokinetic-guided prophylaxis based on Bayesian models with myPKFiT®

Published:2018-07-20 Issue:5 Volume:24 Page:e338-e343
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Mingot-Castellano M. E.¹^ORCID,Parra R.²,Núñez R.³,Martorell M.²

Affiliation:

1. Hospital Regional Universitario de Málaga; Málaga Spain

2. Hospital de la Vall d’Hebron; Barcelona Spain

3. Hospital Universitario Virgen del Rocío; Seville Spain

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13540/fullpdf

Reference19 articles.

1. Guidelines for the management of hemophilia;Srivastava;Haemophilia,2013

2. Considerations in individualizing prophylaxis in patients with haemophilia A;Valentino;Haemophilia,2014

3. Pattern of bleeding in a large prospective cohort of haemophilia A patients: a three-year follow-up of the AHEAD (Advate in HaEmophilia A outcome Database) study;Khair;Haemophilia,2017

4. Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens;Oldenburg;Blood,2015

5. Individualizing prophylaxis in hemophilia: a review;Petrini;Expert Rev Hematol,2015

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the relationship between condition severity and health-related quality of life in people with haemophilia A across Europe: a multivariable analysis of data from the CHESS II study;Health and Quality of Life Outcomes;2024-07-29

2. The Role of Clot Waveform Analysis and Related Parameters in the Diagnosis and Treatment of Hemophilia A;Thrombosis and Haemostasis;2024-04-16

3. Classification of recombinant factor VIII products and implications for clinical practice: A systematic literature review;Haemophilia;2024-03-29

4. Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and B;Research and Practice in Thrombosis and Haemostasis;2024-03

5. Real-world clinical and psychosocial outcomes among people with mild or moderate haemophilia A treated on-demand in the Italian CHESS II cohort: a real-world data analysis;The Journal of Haemophilia Practice;2024-01-01